Any feedback?
Literature summary for 2.7.1.40 extracted from
- Effect of exogenous adenosine and monensin on glycolytic flux in isolated perfused normoxic rat hearts: role of pyruvate kinase (2005), Mol. Cell. Biochem., 277, 55-61.
Activating Compound
| Activating Compound | Comment | Organism | Structure |
|---|---|---|---|
| Myxothiazol | 0.0001 mM | Rattus norvegicus |  |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| adenosine | 0.01 mM | Rattus norvegicus | |
| hexanoate | 0.5 mM | Rattus norvegicus | |
| MgATP2- | potent inhibitor | Rattus norvegicus | |
| monensin | 0.0005 mM | Rattus norvegicus | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Rattus norvegicus | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| heart | - |
Rattus norvegicus | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| ADP + phosphoenolpyruvate | - |
Rattus norvegicus | ATP + pyruvate | - |
? | |
Cofactor
| Cofactor | Comment | Organism | Structure |
|---|---|---|---|
| ADP | - |
Rattus norvegicus | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
